This April, Harvard’s Business School (HBS) will be hosting a leadership development program for pharmaceutical and biotech industry leaders in order to help executives develop and succeed in this rapidly changing industry.
Due to the transformation of the economics of healthcare and the mergers, continually developing technology, acquisitions and government regulations there are many new trials as well as opportunities for the leaders in this industry. David B. Yoffie, Max and Doris Starr Professor of International Business Administration and Senior Associate Dean and Chair of Executive Education stated, “Participants will further develop leadership skills to improve corporate performance and tackle management challenges unique to the fast-evolving pharmaceutical and biotech environment.”
It isn’t only the pharmaceutical and biotech industry that are undergoing vast changes, but many other industries are facing the exact same situation. This can either be an ample opportunity or it can turn into defeat.
If you are ready to have your company keep up with these changes then give us a call at (407) 217-2560. We are here to help you and your company succeed.
Click here to read the press release from Harvard.
